• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

甲基化特异性PCR(MSP)和定量甲基化特异性PCR(qMSP)检测配对的冰冻和福尔马林固定石蜡包埋胶质瘤的比较

A Comparison of Testing by MSP and qMSP in Paired Snap-Frozen and Formalin-Fixed Paraffin-Embedded Gliomas.

作者信息

Lazarević Milica, Jovanović Nikola, Cvetković Vladimir J, Tošić Svetlana, Vitorović Jelena, Stamenković Slaviša, Nikolov Vesna, Vidović Nataša, Kostić Perić Jelena, Jovanović Marija, Mitrović Tatjana

机构信息

Laboratory for Molecular Biology and Biotechnology, Department of Biology and Ecology, Faculty of Sciences and Mathematics, University of Niš, 18000 Niš, Serbia.

Faculty of Medicine, Clinic of Neurosurgery, Clinical Centre, University of Niš, 18000 Niš, Serbia.

出版信息

Diagnostics (Basel). 2023 Jan 18;13(3):360. doi: 10.3390/diagnostics13030360.

DOI:10.3390/diagnostics13030360
PMID:36766464
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9914267/
Abstract

Comparative analysis of the conventional methylation-specific PCR (MSP) vs. the quantitative MSP (qMSP) assessment of the O-methylguanine-DNA methyltransferase () promoter methylation status in 34 snap-frozen (SF) glioma samples was performed. The accuracy of the semi-quantitative MSP was compared with the corresponding qMSP semi-quantitative values using two semi-quantitative cut-off values (0-unmethylated and 1-weakly methylated) to discriminate methylated from unmethylated samples. In the case of the cut-off value 0, MSP test showed 80.0% sensitivity and 78.9% specificity compared to the reference qMSP analysis. However, when using the cut-off value 1, the diagnostic accuracy of the MSP test was significantly higher (85.7% sensitivity, 85.2% specificity). Fleiss' Kappa statistical analyses indicated moderate agreement (Fleiss' Kappa Coefficient = 0.509; 70.59% agreement) between MSP and qMSP semi-quantitative measurements of promoter methylation in glioma patients, justifying the conventional MSP use in diagnostics and confirming its high reliability. Further, we aimed to compare the validity of SF and formalin-fixed paraffin-embedded (FFPE) glioma samples for testing. Statistical analyses indicated moderate overall agreement of FFPE glioma samples and SF MSP semi-quantitative measurements (Fleiss' Kappa Coefficient = 0.516/0.509; 70.0% agreement) and emphasized their low reliability in the assessment of highly methylated promoter samples.

摘要

对34例速冻(SF)胶质瘤样本中O-甲基鸟嘌呤-DNA甲基转移酶()启动子甲基化状态进行常规甲基化特异性PCR(MSP)与定量MSP(qMSP)评估的比较分析。使用两个半定量临界值(0-未甲基化和1-弱甲基化)将甲基化样本与未甲基化样本区分开来,将半定量MSP的准确性与相应的qMSP半定量值进行比较。在临界值为0的情况下,与参考qMSP分析相比,MSP检测显示出80.0%的灵敏度和78.9%的特异性。然而,当使用临界值1时,MSP检测的诊断准确性显著更高(灵敏度为85.7%,特异性为85.2%)。Fleiss' Kappa统计分析表明,MSP与qMSP对胶质瘤患者启动子甲基化的半定量测量之间存在中度一致性(Fleiss' Kappa系数 = 0.509;一致性为70.59%),这证明了常规MSP在诊断中的应用合理性,并证实了其高可靠性。此外,我们旨在比较SF和福尔马林固定石蜡包埋(FFPE)胶质瘤样本用于检测的有效性。统计分析表明,FFPE胶质瘤样本与SF MSP半定量测量之间总体一致性适中(Fleiss' Kappa系数 = 0.516/0.509;一致性为70.0%),并强调了它们在评估高度甲基化启动子样本时的低可靠性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57f5/9914267/cc7012ca9dbe/diagnostics-13-00360-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57f5/9914267/f346f3b72bde/diagnostics-13-00360-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57f5/9914267/029c851d6b2e/diagnostics-13-00360-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57f5/9914267/c6ae897b8518/diagnostics-13-00360-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57f5/9914267/c2ef8910f328/diagnostics-13-00360-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57f5/9914267/597b3637b902/diagnostics-13-00360-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57f5/9914267/674002616a97/diagnostics-13-00360-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57f5/9914267/023d02e71aca/diagnostics-13-00360-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57f5/9914267/cc7012ca9dbe/diagnostics-13-00360-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57f5/9914267/f346f3b72bde/diagnostics-13-00360-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57f5/9914267/029c851d6b2e/diagnostics-13-00360-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57f5/9914267/c6ae897b8518/diagnostics-13-00360-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57f5/9914267/c2ef8910f328/diagnostics-13-00360-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57f5/9914267/597b3637b902/diagnostics-13-00360-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57f5/9914267/674002616a97/diagnostics-13-00360-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57f5/9914267/023d02e71aca/diagnostics-13-00360-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57f5/9914267/cc7012ca9dbe/diagnostics-13-00360-g008.jpg

相似文献

1
A Comparison of Testing by MSP and qMSP in Paired Snap-Frozen and Formalin-Fixed Paraffin-Embedded Gliomas.甲基化特异性PCR(MSP)和定量甲基化特异性PCR(qMSP)检测配对的冰冻和福尔马林固定石蜡包埋胶质瘤的比较
Diagnostics (Basel). 2023 Jan 18;13(3):360. doi: 10.3390/diagnostics13030360.
2
MGMT promoter methylation determined by HRM in comparison to MSP and pyrosequencing for predicting high-grade glioma response.通过高分辨率熔解曲线分析(HRM)测定的O6-甲基鸟嘌呤-DNA甲基转移酶(MGMT)启动子甲基化与甲基化特异性PCR(MSP)和焦磷酸测序相比,用于预测高级别胶质瘤的反应。
Clin Epigenetics. 2016 May 5;8:49. doi: 10.1186/s13148-016-0204-7. eCollection 2016.
3
Reliability and reproducibility of PCR-based testing of O6-methylguanine-DNA methyltransferase gene (MGMT) promoter methylation status in formalin-fixed and paraffin-embedded neurosurgical biopsy specimens.基于聚合酶链反应(PCR)检测福尔马林固定石蜡包埋神经外科活检标本中O6-甲基鸟嘌呤-DNA甲基转移酶基因(MGMT)启动子甲基化状态的可靠性和可重复性。
Clin Neuropathol. 2008 Nov-Dec;27(6):388-90. doi: 10.5414/npp27388.
4
Validation of real-time methylation-specific PCR to determine O6-methylguanine-DNA methyltransferase gene promoter methylation in glioma.用于确定胶质瘤中O6-甲基鸟嘌呤-DNA甲基转移酶基因启动子甲基化的实时甲基化特异性PCR的验证
J Mol Diagn. 2008 Jul;10(4):332-7. doi: 10.2353/jmoldx.2008.070169. Epub 2008 Jun 13.
5
MGMT promoter methylation in gliomas-assessment by pyrosequencing and quantitative methylation-specific PCR.MGMT 启动子甲基化在神经胶质瘤中的评估——焦磷酸测序和定量甲基化特异性 PCR 法。
J Transl Med. 2012 Mar 6;10:36. doi: 10.1186/1479-5876-10-36.
6
MGMT promoter methylation and glioblastoma: a comparison of analytical methods and of tumor specimens.O6-甲基鸟嘌呤-DNA甲基转移酶(MGMT)启动子甲基化与胶质母细胞瘤:分析方法及肿瘤标本的比较
Int J Biol Markers. 2015 May 26;30(2):e208-16. doi: 10.5301/jbm.5000126.
7
Increased expression of the histone H3 lysine 4 methyltransferase MLL4 and the histone H3 lysine 27 demethylase UTX prolonging the overall survival of patients with glioblastoma and a methylated MGMT promoter.组蛋白 H3 赖氨酸 4 甲基转移酶 MLL4 和组蛋白 H3 赖氨酸 27 去甲基酶 UTX 的表达增加,延长了具有甲基化 MGMT 启动子的胶质母细胞瘤患者的总生存期。
J Neurosurg. 2017 May;126(5):1461-1471. doi: 10.3171/2016.4.JNS1652. Epub 2016 Jul 1.
8
Frequent MGMT (0(6)-methylguanine-DNA methyltransferase) hypermethylation in long-term survivors of glioblastoma: a single institution experience.胶质母细胞瘤长期幸存者中频繁的 MGMT(O(6)-甲基鸟嘌呤-DNA 甲基转移酶)甲基化:单机构经验。
Radiol Oncol. 2010 Jun;44(2):113-20. doi: 10.2478/v10019-010-0023-y. Epub 2010 May 24.
9
Comparative assessment of three methods to analyze MGMT methylation status in a series of 350 gliomas and gangliogliomas.对350例胶质瘤和神经节胶质瘤系列中三种分析MGMT甲基化状态方法的比较评估。
Pathol Res Pract. 2017 Dec;213(12):1489-1493. doi: 10.1016/j.prp.2017.10.007. Epub 2017 Oct 10.
10
Clinical validation of a novel quantitative assay for the detection of MGMT methylation in glioblastoma patients.新型定量检测试剂盒在胶质母细胞瘤患者 MGMT 甲基化检测中的临床验证。
Clin Epigenetics. 2021 Mar 9;13(1):52. doi: 10.1186/s13148-021-01044-2.

引用本文的文献

1
The epigenetic modification of DNA methylation in neurological diseases.神经疾病中的 DNA 甲基化的表观遗传修饰。
Front Immunol. 2024 Sep 23;15:1401962. doi: 10.3389/fimmu.2024.1401962. eCollection 2024.

本文引用的文献

1
The Significance of Promoter Methylation Status in Diffuse Glioma.启动子甲基化状态在弥漫性神经胶质瘤中的意义。
Int J Mol Sci. 2022 Oct 27;23(21):13034. doi: 10.3390/ijms232113034.
2
Burden and trends of brain and central nervous system cancer from 1990 to 2019 at the global, regional, and country levels.1990年至2019年全球、区域和国家层面脑及中枢神经系统癌症的负担与趋势。
Arch Public Health. 2022 Sep 17;80(1):209. doi: 10.1186/s13690-022-00965-5.
3
Primary brain and other central nervous system tumors in the United States (2014-2018): A summary of the CBTRUS statistical report for clinicians.
美国原发性脑肿瘤和其他中枢神经系统肿瘤(2014 - 2018年):临床医生CBTRUS统计报告摘要
Neurooncol Pract. 2022 Feb 22;9(3):165-182. doi: 10.1093/nop/npac015. eCollection 2022 May.
4
The 2021 WHO Classification of Tumors of the Central Nervous System: a summary.2021 年世卫组织中枢神经系统肿瘤分类:概述。
Neuro Oncol. 2021 Aug 2;23(8):1231-1251. doi: 10.1093/neuonc/noab106.
5
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.《全球癌症统计数据 2020:全球 185 个国家和地区 36 种癌症的发病率和死亡率估计》。
CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4.
6
EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood.EANO 成人弥漫性胶质瘤诊断与治疗指南。
Nat Rev Clin Oncol. 2021 Mar;18(3):170-186. doi: 10.1038/s41571-020-00447-z. Epub 2020 Dec 8.
7
Real-World Evidence in Glioblastoma: Stupp's Regimen After a Decade.胶质母细胞瘤的真实世界证据:十年后的施图普方案
Front Oncol. 2020 Jul 3;10:840. doi: 10.3389/fonc.2020.00840. eCollection 2020.
8
Do we really know who has an methylated glioma? Results of an international survey regarding use of analyses for glioma.我们真的知道谁患有甲基化胶质瘤吗?一项关于胶质瘤分析方法使用情况的国际调查结果。
Neurooncol Pract. 2020 Jan;7(1):68-76. doi: 10.1093/nop/npz039. Epub 2019 Sep 24.
9
O-Methylguanine-DNA Methyltransferase (MGMT): Challenges and New Opportunities in Glioma Chemotherapy.O-甲基鸟嘌呤-DNA甲基转移酶(MGMT):胶质瘤化疗中的挑战与新机遇
Front Oncol. 2020 Jan 17;9:1547. doi: 10.3389/fonc.2019.01547. eCollection 2019.
10
Weak MGMT gene promoter methylation confers a clinically significant survival benefit in patients with newly diagnosed glioblastoma: a retrospective cohort study.弱 MGMT 基因启动子甲基化可为新诊断的胶质母细胞瘤患者带来显著的临床生存获益:一项回顾性队列研究。
J Neurooncol. 2020 Jan;146(1):55-62. doi: 10.1007/s11060-019-03334-5. Epub 2019 Nov 7.